271 related articles for article (PubMed ID: 25632938)
1. Adeno-associated virus-mediated microRNA delivery and therapeutics.
Xie J; Burt DR; Gao G
Semin Liver Dis; 2015 Feb; 35(1):81-8. PubMed ID: 25632938
[TBL] [Abstract][Full Text] [Related]
2. Long-term, efficient inhibition of microRNA function in mice using rAAV vectors.
Xie J; Ameres SL; Friedline R; Hung JH; Zhang Y; Xie Q; Zhong L; Su Q; He R; Li M; Li H; Mu X; Zhang H; Broderick JA; Kim JK; Weng Z; Flotte TR; Zamore PD; Gao G
Nat Methods; 2012 Mar; 9(4):403-9. PubMed ID: 22388288
[TBL] [Abstract][Full Text] [Related]
3. Circumventing cellular immunity by miR142-mediated regulation sufficiently supports rAAV-delivered OVA expression without activating humoral immunity.
Xiao Y; Muhuri M; Li S; Qin W; Xu G; Luo L; Li J; Letizia AJ; Wang SK; Chan YK; Wang C; Fuchs SP; Wang D; Su Q; Nahid MA; Church GM; Farzan M; Yang L; Wei Y; Desrosiers RC; Mueller C; Tai PW; Gao G
JCI Insight; 2019 May; 5(13):. PubMed ID: 31112525
[TBL] [Abstract][Full Text] [Related]
4. Gene transfer in the liver using recombinant adeno-associated virus.
Ahmed SS; Li J; Godwin J; Gao G; Zhong L
Curr Protoc Microbiol; 2013; Chapter 14():14D.6.1-14D.6.32. PubMed ID: 23686826
[TBL] [Abstract][Full Text] [Related]
5. Identification and Validation of Small Molecules That Enhance Recombinant Adeno-associated Virus Transduction following High-Throughput Screens.
Nicolson SC; Li C; Hirsch ML; Setola V; Samulski RJ
J Virol; 2016 Aug; 90(16):7019-7031. PubMed ID: 27147738
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hepatitis C virus replication using adeno-associated virus vector delivery of an exogenous anti-hepatitis C virus microRNA cluster.
Yang X; Haurigot V; Zhou S; Luo G; Couto LB
Hepatology; 2010 Dec; 52(6):1877-87. PubMed ID: 20931557
[TBL] [Abstract][Full Text] [Related]
7. A Comparison of Inducible Gene Expression Platforms: Implications for Recombinant Adeno-Associated Virus (rAAV) Vector-Mediated Ocular Gene Therapy.
Lipinski DM
Adv Exp Med Biol; 2019; 1185():79-83. PubMed ID: 31884592
[TBL] [Abstract][Full Text] [Related]
8. Controlled release strategies for rAAV-mediated gene delivery.
Rey-Rico A; Cucchiarini M
Acta Biomater; 2016 Jan; 29():1-10. PubMed ID: 26472612
[TBL] [Abstract][Full Text] [Related]
9. rAAV6-mediated miR-29b delivery suppresses renal fibrosis.
Saito S; Ohno SI; Harada Y; Oikawa K; Fujita K; Mineo S; Gondo A; Kanno Y; Kuroda M
Clin Exp Nephrol; 2019 Dec; 23(12):1345-1356. PubMed ID: 31482255
[TBL] [Abstract][Full Text] [Related]
10. Profiling of microRNA as a tool to introduce rAAV vectors in gene therapy of breast cancer: A preliminary report.
Zajkowska A; Czajka M; Gulik K; Gawrychowski K; Małecki M
Adv Clin Exp Med; 2023 Oct; 32(10):1201-1210. PubMed ID: 37771218
[TBL] [Abstract][Full Text] [Related]
11. A new method for recombinant adeno-associated virus vector delivery to murine diaphragm.
Mah C; Fraites TJ; Cresawn KO; Zolotukhin I; Lewis MA; Byrne BJ
Mol Ther; 2004 Mar; 9(3):458-63. PubMed ID: 15006614
[TBL] [Abstract][Full Text] [Related]
12. Progress in microRNA delivery.
Zhang Y; Wang Z; Gemeinhart RA
J Control Release; 2013 Dec; 172(3):962-74. PubMed ID: 24075926
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA: Promising Roles in Cancer Therapy.
Hashemi A; Gorji-Bahri G
Curr Pharm Biotechnol; 2020; 21(12):1186-1203. PubMed ID: 32310047
[TBL] [Abstract][Full Text] [Related]
14. Recombinant adeno-associated virus-mediated gene transfer for the potential therapy of adenosine deaminase-deficient severe combined immune deficiency.
Silver JN; Elder M; Conlon T; Cruz P; Wright AJ; Srivastava A; Flotte TR
Hum Gene Ther; 2011 Aug; 22(8):935-49. PubMed ID: 21142972
[TBL] [Abstract][Full Text] [Related]
15. Production of recombinant adeno-associated viral vectors and use in in vitro and in vivo administration.
Gray SJ; Choi VW; Asokan A; Haberman RA; McCown TJ; Samulski RJ
Curr Protoc Neurosci; 2011 Oct; Chapter 4():Unit 4.17. PubMed ID: 21971848
[TBL] [Abstract][Full Text] [Related]
16. Recombinant adeno-associated virus type 2-mediated gene transfer into human keratinocytes is influenced by both the ubiquitin/proteasome pathway and epidermal growth factor receptor tyrosine kinase.
Braun-Falco M; Eisenried A; Büning H; Ring J
Arch Dermatol Res; 2005 May; 296(11):528-35. PubMed ID: 15776248
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-based therapeutics for cancer.
Wang V; Wu W
BioDrugs; 2009; 23(1):15-23. PubMed ID: 19344188
[TBL] [Abstract][Full Text] [Related]
18. Adeno-Associated Virus (AAV) Gene Delivery: Dissecting Molecular Interactions upon Cell Entry.
Large EE; Silveria MA; Zane GM; Weerakoon O; Chapman MS
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372542
[TBL] [Abstract][Full Text] [Related]
19. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis.
Ulrich-Vinther M; Carmody EE; Goater JJ; S balle K; O'Keefe RJ; Schwarz EM
J Bone Joint Surg Am; 2002 Aug; 84(8):1405-12. PubMed ID: 12177271
[TBL] [Abstract][Full Text] [Related]
20. Production of clinical-grade recombinant adeno-associated virus vectors.
Snyder RO; Flotte TR
Curr Opin Biotechnol; 2002 Oct; 13(5):418-23. PubMed ID: 12459331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
